Shinhan Investment Co. prepares exclusive technical listing ... Focuses on the medical image analysis solution 'DEEP: PHI.'
DEEPNOID, a medical AI company founded in 2008, will promote Initial Public Offering (IPO). After signing a contract with Shinhan Investment Co., DEEPNOID, which started working on the IPO, is striving to enter the KOSDAQ the following year. The main business area is medical AI, specifically creating an accurate and objective medical image reading standards by designing a solution model that helps the doctor's reading process.